| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 249 | 2021 |
| Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses OE Sørensen, SN Clemmensen, SL Dahl, O Østergaard, NH Heegaard, ... The Journal of clinical investigation 124 (10), 4539-4548, 2014 | 173 | 2014 |
| Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug A Glenthoj, BY Glenthoj, T Mackeprang, AK Pagsberg, RP Hemmingsen, ... Psychiatry Research: Neuroimaging 154 (3), 199-208, 2007 | 151 | 2007 |
| Olfactomedin 4 defines a subset of human neutrophils SN Clemmensen, CT Bohr, S Rørvig, A Glenthøj, H Mora-Jensen, ... Journal of leukocyte biology 91 (3), 495-500, 2012 | 136 | 2012 |
| Candida albicans escapes from mouse neutrophils D Ermert, MJ Niemiec, M Röhm, A Glenthøj, N Borregaard, CF Urban Journal of leukocyte biology 94 (2), 223-236, 2013 | 88 | 2013 |
| COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA L Pagano, J Salmanton-García, F Marchesi, A López-García, S Lamure, ... Blood, The Journal of the American Society of Hematology 139 (10), 1588-1592, 2022 | 81 | 2022 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 76 | 2021 |
| Immune mechanisms in myelodysplastic syndrome A Glenthøj, AD Ørskov, JW Hansen, SR Hadrup, C O’Connell, K Grønbæk International journal of molecular sciences 17 (6), 944, 2016 | 74 | 2016 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 62 | 2022 |
| Mitapivat versus placebo for pyruvate kinase deficiency H Al-Samkari, F Galactéros, A Glenthøj, JA Rothman, O Andres, RF Grace, ... New England Journal of Medicine 386 (15), 1432-1442, 2022 | 52 | 2022 |
| miRNA-130a regulates C/EBP-ε expression during granulopoiesis MT Larsen, M Häger, A Glenthøj, F Asmar, SN Clemmensen, ... Blood, The Journal of the American Society of Hematology 123 (7), 1079-1089, 2014 | 51 | 2014 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 49 | 2022 |
| The variable manifestations of disease in pyruvate kinase deficiency and their management H Al-Samkari, EJ Van Beers, KHM Kuo, W Barcellini, P Bianchi, ... Haematologica 105 (9), 2229, 2020 | 37 | 2020 |
| Clinical presentation and mortality in hospitalized patients aged 80+ years with COVID-19–a retrospective cohort study LK Karlsson, LH Jakobsen, L Hollensberg, J Ryg, M Midttun, ... Archives of gerontology and geriatrics 94, 104335, 2021 | 31 | 2021 |
| No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer EP Cramer, A Glenthøj, M Häger, A Juncker-Jensen, LH Engelholm, ... PLoS One 7 (6), e39646, 2012 | 29 | 2012 |
| Evans syndrome in adults: an observational multicenter study B Fattizzo, M Michel, JA Giannotta, DL Hansen, M Arguello, E Sutto, ... Blood advances 5 (24), 5468-5478, 2021 | 28 | 2021 |
| Improved clinical outcome of COVID‐19 in hematologic malignancy patients receiving a fourth dose of anti‐SARS‐CoV‐2 vaccine: an EPICOVIDEHA report J Salmanton‐García, F Marchesi, A Glenthøj, YM Bilgin, J Van Praet, ... Hemasphere 6 (11), e789, 2022 | 27 | 2022 |
| Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial C Fuchs Andersen, M Omar, A Glenthøj, D El Fassi, HJ Møller, ... European Journal of Heart Failure 25 (2), 226-234, 2023 | 26 | 2023 |
| SARS‐CoV‐2 infection among patients with haematological disorders: severity and one‐month outcome in 66 Danish patients in a nationwide cohort study A Glenthøj, LH Jakobsen, H Sengeløv, SA Ahmad, K Qvist, A Rewes, ... European journal of haematology 106 (1), 72-81, 2021 | 25 | 2021 |
| Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial A Glenthøj, EJ van Beers, H Al-Samkari, V Viprakasit, KHM Kuo, ... The Lancet Haematology 9 (10), e724-e732, 2022 | 24 | 2022 |
Eduard J van BeersHematologist, Van Creveldkliniek, University Medical Center, Utrecht, the NetherlandsVerified email at umcutrecht.nl
